Podcasts about infectious diseases

A surprising rise in Cyclospora infections is making headlines across the United States. But what exactly is Cyclospora, why are cases increasing this summer, and how can you protect yourself and your family? In this episode of The Lebanese Physicians Podcast, I speak with Dr. Wassim Abdallah, Infectious Diseases specialistt at Emory University, about the science behind the current outbreak. We discuss how Cyclospora spreads through contaminated produce, why climate change and global food supply chains may be contributing to rising cases, the latest diagnostic and treatment strategies, and practical prevention tips for both healthcare professionals and the general public. Whether you're a clinician or simply trying to stay informed, this episode provides evidence-based guidance on one of this summer's most talked-about foodborne illnesses. #Cyclospora #FoodSafety #InfectiousDiseases #PublicHealth #Diarrhea #FoodborneIllness #EmoryUniversity #Healthcare #Medicine #CDC #Physician #MedicalEducation #ClimateChange #PreventiveMedicine #TheLebanesePhysiciansPodcast

A new report highlights the consequences of infectious diseases extending beyond the acute phase of the illness. We spoke with Dr. Fred Browne of Griffin Health about illnesses like the flu, covid and pneumonia being linked to more long-term issues like stroke and how we can have more control over increasing our risk. We also talked about the latest with cyclospora cases in Connecticut.Image Courtesy of Griffin Health and Dr. Fred Browne

July 16, 2026 ~ Dr. Teena Chopra, Professor of Internal Medicine in the Division of Infectious Diseases, joins Marie Osborne to explain what listeners need to know as health officials continue to investigate cases linked to the recent Cyclosporiasis outbreak. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

July 16, 2026 ~ Marie Osborne sits in for Kevin today and talks with Dr. Shelley Schmidt, a Pulmonologist at Corewell Health about how to stay safe with the poor air quality, Dr. Teena Chopra, Professor of Internal Medicine at Wayne State University, Division of Infectious Diseases about the current state of the cyclosporiasis outbreak, and hosts a special hour of All Talk where she discusses living kidney donation. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In episode 82 of Going anti-Viral, Dr Tyler Evans joins host Dr Michael Saag to discuss the Ebola outbreak in the Democratic Republic of the Congo and Uganda and the global response. Dr Evans is an infectious diseases and addiction medicine physician and CEO of Wellness Equity Alliance, a national organization advancing health equity in the US and globally. He is also an associate professor of population and public health sciences at the University of Southern California Keck School of Medicine and the author of Pandemics, Poverty, and Politics, which examines how socially and politically determined inequalities, have consistently precipitated pandemics and public health emergencies. Dr Evans' work spans street medicine, HIV/AIDS care, and humanitarian response in complex emergencies, including 2 Ebola response missions. Dr Evans and Dr Saag discuss the current Ebola outbreak, its transmission, challenges in containment, and the likelihood for a vaccine. They also explore the impact of public trust on care and provide an update on the response from US and international agencies including a discussion of the risk for the outbreak to spread globally.  0:00 – Introduction 1:33 – Understanding Ebola: transmission and symptoms3:05 – Containment strategies for Ebola outbreaks7:39 – Challenges in surveillance and response11:09 – Urban spread of Ebola: risks and concerns12:43 – Vaccination strategies and developments15:58 – Conditions in treatment centers and the impact of public trust in the outbreak21:04 – Update on the response from US and international agencies and risk of spread to the US and globallyResources:Pandemics, Poverty, and Politics: https://www.tylerevansmd.com/ Wellness Equity Alliance: https://www.wellnessequityalliance.com/ __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Cyclosporiasis has affected thousands across the US, including some people in Louisiana. What is it? How do we catch it? Dr. Fred Lopez, Professor of Medicine in the Section of Infectious Diseases at LSU Health New Orleans, joins us to explain.

This is the second episode of in the series, [Contagious Conversations] from the Australasian Society for Infectious Diseases. Expert guests in this series will come from right across the interface of research, clinical care and public health.In today's episode we look at the immense progress that has been made over three decades in the management of HIV. Once a fatal diagnosis, the disease can now be completely controlled by anti-retroviral therapy. Access to prophylactic treatment has also made a huge impact on rates of transmission in the community although barriers still remain to equitable access.GuestsProfessor Sharon Lewin OA FRACP PhD (Peter Doherty Institute for Infection and Immunity, Director; University of Melbourne; Cumming Global Centre for Pandemic Therapeutics, Director)Professor Dato' Dr Adeeba Kamarulzaman FRACP FASc (Monash University Malaysia, President & Pro Vice-Chancellor; Centre of Excellence for Research in AIDS).Richard Keane (Living Positive Victoria, CEO)HostAssociate Professor Sanjaya Senanayake FRACP (Canberra Hospital; Australian National University)ProductionProduction supported by Mic Cavazzini DPhil, and the Viral Hepatitis and HIV Special Interest Group particularly Dr Emma Paige and Dr Sushena Krishnaswamy. Thanks also to Inge Meggitt, events coordinator at ASID. Music licenced from Epidemic Sound includes ‘Exploring the Lake' by View Points and ‘Emerlyn' by Valante. Image copyright ASID (2026).Visit the Pomegranate Health web page for a transcript and supporting references. Add educational activity to MyCPD. Subscribe through any podcasting app or our email alerts list. 

July 8, 2026 ~ Dr. Cindy McCartney MD, Infectious Disease physician, Medical Director of Infection Prevention at Henry Ford Macomb discusses another spike in Cyclosporiasis. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode Notes In this episode, DASON Clinical Pharmacist Liaison Dr. Melissa Johnson, talks with us about an article in ASHE entitled "Antimicrobial and diagnostic stewardship: opportunities for return on investment," that can be viewed here: https://pubmed.ncbi.nlm.nih.gov/42238730/ Environmental Stewardship in Infectious Diseases was also mentioned, and can be found here: https://sustainabil-id.com/ For more information about DASON, please visit: https://dason.medicine.duke.edu/

Send us Fan MailThe COVID-19 pandemic proved vaccine platforms can move at unprecedented speed. It also revealed how dangerously narrow the world's response really was, built almost entirely on a single technology.Dr. Dan Barouch and Kris Brown, Co-Founders of Vector Sciences, join host David E. Williams to discuss why durable pandemic preparedness depends on having multiple vaccine platforms rather than just one, how their Rheovax platform uses mucosal immunity delivered through the nose to block transmission rather than just prevent severe disease, and why public trust in vaccines depends on being honest about what each technology can and cannot actually do.

Gut health trends are everywhere, but which ones deserve a closer look, and which ones need a reality check?In this episode, we break down the biggest gut health trends getting clicks, likes, and follows online. From our "hard no" to "I'm curious," we share where each trend lands on our hype scale and explain the science, physiology, and gut-brain connection behind our take.We explore what actually helps symptoms like constipation, bloating, and digestive discomfort without fueling anxiety, wasting money, or creating unnecessary health risks.From viral wellness trends to evidence-based advice, here's what we're discussing:Does the viral chia seed "internal shower" actually cleanse your colon or is that just clever marketing?Are colonics and coffee enemas detox heroes, or do they go against how your gut is designed to work?Can lemon water and apple cider vinegar really "wake up" your digestion first thing in the morning?Can a simple self-care routine improve your gut symptoms, even if it doesn't "heal" your digestive system?Are fermented foods always packed with probiotics or is there more to the story? (Tune in for a revisit of Episode 20!)Can you make colonoscopy prep more tolerable with "prep mocktails" without interfering with the procedure?Can you have too much of a good thing? What happens when "fibermaxxing" goes too far?Are gut-healing protocols and at-home microbiome tests helping you understand your gut or making you more confused and anxious?Do lactose intolerance patches actually work, or does the science tell a different story?Are castor oil packs a legitimate digestive therapy?Whether you're tempted to try the latest gut health hack or just wondering what's worth your attention, this episode will help you separate science from social media. Resources:Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders. Food Sci Nutr. 2022 Dec 15;11(1):3-16. doi: 10.1002/fsn3.3035.Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024. doi: 10.1093/cid/ciae104.Fermented Foods via ISAPPMisselwitz B, Butter M, Verbeke K, Fox MR. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut. 2019 Nov;68(11):2080-2091. doi: 10.1136/gutjnl-2019-318404. Epub 2019 Aug 19. PMID: 31427404; PMCID: PMC6839734.Learn more about Kate and Dr. Riehl:Website: www.katescarlata.com and www.drriehl.comInstagram: @katescarlata @drriehl and @theguthealthpodcastOrder Kate and Dr. Riehl's book, Mind Your Gut: The Science-Based, Whole-body Guide to Living Well with IBS.  The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment.  Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

Understanding how values and communication styles differ across cultures is key to succeeding internationally. That’s why training in cross-cultural communication has become commonplace in the international business world. In this session, we’ll look at 6 dimensions of cross-cultural communication and their application to medical scenarios.

Why does an undetectable HIV viral load sometimes flip to “detectable” — and what does that actually mean for the patient? Host Ben Plumley talks with Ben LaBrot (Professor of Global Medicine, USC; Medical Affairs Lead, Roche Molecular Diagnostics) and Daniel Griffin, MD (Chief of Infectious Disease, Island Infectious Disease Medical, Instructor of Clinical Medicine, Columbia University, Host, This Week in Virology) about the “viral blip” — a brief, low-level detectable result that occurs even in patients on fully effective antiretroviral therapy. The conversation covers the science behind ultra-sensitive viral load assays, the real meaning of U=U (undetectable = untransmittable), why lab handling and patient illness can cause a temporary blip, and why so many patients are blindsided by results in their MyChart before their doctor has a chance to explain. Ben and Daniel also discuss “prebunking” — preparing patients in advance — and the underused role of community health workers in HIV education. Topics: HIV, viral load, U=U, undetectable, antiretroviral therapy, infectious disease, diagnostics, patient communication, global health. 00:00 Welcome and Setup 00:13 The Viral Blip Riddle 01:20 Meet the Guests 04:02 Why Blips Matter Now 05:54 Assay Sensitivity and LOD 06:22 What Undetectable Means 08:36 U Equals U Confusion 12:50 MyChart Panic and Context 17:09 Prebunking Patient Fear 18:21 Why Blips Happen 20:59 Tech Problem Analog Fix 22:26 Testing Noise Sources 23:28 RNA Fragments Explained 25:16 Sample Handling Pitfalls 26:46 Reporting Low Copy Results 29:02 Managing Patient Anxiety 33:14 When a Blip Matters 36:12 Changing the Landscape 40:48 Community Outreach Ideas 43:12 Key Takeaways Check Out Ben's Substack: https://substack.com/@benplumley1 Join the Conversation! How do you see the future of global health unfolding? Share your thoughts in the comments! Subscribe & Stay Updated: Listen on Spotify, Apple Podcasts, or your favorite podcast platform. Watch on YouTube & subscribe for more in-depth global health.

In episode 81 of Going anti-Viral, Dr Steven Deeks joins host Dr Michael Saag to discuss recent research demonstrating the promise of a single shot in a functional cure of HIV. Dr Deeks is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment and is the contact principal investigator of the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. Dr Deeks and Dr Saag discuss why a cure for HIV is needed given the effectiveness antiretroviral therapy. Dr Deeks then outlines areas of research demonstrating promise for single-shot functional cures: vector immunotherapy, the use of Chimeric Antigen Receptor (CAR) T cells, and stem cell approaches. Finally, Dr Deeks provides insights into future prospects in HIV cure research including his perspective on the funding and drug development landscape. 0:00 – Introduction 1:21 – The need for a cure beyond antiretroviral therapy5:37 – Overview of 1-shot cure research  12:40 – The promise of vector immunotherapy18:52 – Overview of the use of CAR-T cells 25:01 – The role of C-C chemokine receptor type 5 (CCR5) and stem cell approaches26:36 – Prospects for the future of HIV cure research __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Send us Fan MailMore than 200 million people around the world are infected with schistosomiasis, one of the neglected tropical diseases. It is caused by parasitic worms and prevalent in Africa, the Middle East, South America and Asia with close to 800 million people at risk for infection. If we in the U.S. are not in immediate threat of contracting the disease, why should we want to know more about it? To answer that and to explain more about the disease –– how people are infected, who is at risk, what the symptoms are and how it's currently treated –– is Afzal Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor, director of the TTUHSC Center for Tropical Medicine and Infectious Diseases and chair of the Department of Immunology and Molecular Microbiology in TTUHSC's School of Medicine. Siddiqui also shares with us his decades-long work as part of a team developing a vaccine, updates us on the progress of the clinical trials and how work done on this vaccine could be useful to develop other vaccines as well. About SchistoShield®

Saving The World From Soda: How ‘Big Soda' Has Made The World Sicker Would you believe that the soda industry's success is largely built on the manipulation of data and scientists? Our guest this week details all the behind-the-scenes scheming that created a billion-dollar industry. She discusses how Big Soda schemed their way into American homes by controlling how scientists studied nutrition, diets, and obesity. Guest: Susan Greenhalgh, author, Soda Science, John King & Wilma Cannon Fairbank Research Professor of Chinese Society Emerita, Harvard University   The Fungal Frontier: How Fungi Could Trigger A Zombie Pandemic Human bodies are normally too hot for dangerous fungi to survive, creating a natural shield that protects us from infection. However, rising global temperatures are forcing these microscopic organisms to adapt and survive in hotter environments. Our guest this week breaks down the terrifying reality of what could happen if these heat-resistant fungi evolve to conquer our immune systems and trigger a real-world pandemic. Guest: Dr. Arturo Casadevall, microbiologist, infectious disease expert, Chair of Molecular Microbiology & Immunology, Bloomberg Distinguished Professor, Johns Hopkins Bloomberg School of Public Health, author, What If Fungi Win? Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Fungal Frontier: How Fungi Could Trigger A Zombie Pandemic Human bodies are normally too hot for dangerous fungi to survive, creating a natural shield that protects us from infection. However, rising global temperatures are forcing these microscopic organisms to adapt and survive in hotter environments. Our guest this week breaks down the terrifying reality of what could happen if these heat-resistant fungi evolve to conquer our immune systems and trigger a real-world pandemic. Guest: Dr. Arturo Casadevall, microbiologist, infectious disease expert, Chair of Molecular Microbiology & Immunology, Bloomberg Distinguished Professor, Johns Hopkins Bloomberg School of Public Health, author, What If Fungi Win? Host: Greg Johnson Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

“Stories … are powerful tools that can help us make sense of our lives,” says physician-scientist Maya Adam. She now combines visual storytelling and health education to create animations that go beyond the barriers of language and culture to convey important health messages. The subject matter ranges from vaccine acceptance and addiction to mental health and nutrition. These emotionally engaging narratives – often without a single spoken word – are more effective than traditional pamphlets and lectures, Adam says. Visual stories have the potential to achieve “near-universal understanding” that can support better health outcomes, she tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Maya Adam Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Maya Adam, a professor of pediatrics and infectious disease from Stanford University. (00:03:43) From Ballet to Medicine How Adam's background shaped her approach to health education. (00:05:02) Why Stories Work Why lived experience makes evidence-based health recommendations more meaningful. (00:06:17) The Story Creation Process Adam's techniques for creating effective scalable health stories on any topic (00:09:20) Real World Stories Adam shares some particularly challenging topics the team has created stories for (00:11:10) Global Accessibility Designing stories and characters that can resonate across cultures and contexts. (00:12:38) Measuring Impact Using technology to run trials to test and measure impact (00:15:23) Iterating the Message Adapting and changing approaches to create the most effective message (00:17:53) AI and Storytelling How AI is beginning to affect health communication and creative production. (00:19:45) Testing Human vs. AI Art A trial comparing responses to human-created and AI-generated health storytelling. (00:25:42) Human-in-the-Loop AI How AI may best support artists and clinicians by reducing burden rather than replacing (00:27:43) Future In a Minute Rapid-fire Q&A: stories, collaboration, media, and the future of health communication. (00:29:44) Conclusion   Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of The ASHE Podcast, hosts Dr. Gonzalo Bearman and Dr. Priya Nori speak with Elizabeth Hirsch, PharmD and David Mott, PhD about their national survey of infectious diseases and antimicrobial stewardship pharmacists in the United States. They discuss the workforce's diverse responsibilities, training and resource challenges, and key findings that have implications for workforce development, retention, and the future of antimicrobial stewardship programs.   Read the full article: Hirsch EB, Mott DA, Gilson AM, et al. A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needs. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1):e76. doi:10.1017/ash.2026.10312

Updated ASTCT infectious disease guidelines are reshaping how BMT and cellular therapy pharmacists approach prophylaxis, treatment thresholds, and drug–drug interactions across a range of opportunistic infections.

On episode #109 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 6/4 – 6/22/26. Host: Daniel Griffin and Sarah Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa (CID) Bacterial Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia(NEJM) A fatal case of Legionella micdadei prosthetic valve endocarditis diagnosed by plasma microbial cell-free DNA metagenomic sequencing (LANCET: Infectious Diseases) Legionnaires Disease Associated with a Private-Use Hot Tub in a Vacation Rental Property — New York, October 2024–April 2025 (CDC: MMWR) Notes from the Field: Case of Legionnaires Disease Associated with a Home Device Used to Mix Powdered Infant Formula — United States, 2025 (CDC:MMWR) Duration of antibiotic therapy for bacteremia in immune compromised hosts—a post hoc subgroup analysis of the BALANCErandomized clinical trial (CMI: Clinical Microbiology and Infection) FDA approves first oral carbapenem therapy for complicated urinary tract infections (FDA) Oral Tebipenem Matched IV antibiotic for complicated UTIs in Phase III Trial (MEDPAGE Today) US FDA approves GSK's oral antibiotic for drug-resistant UTIs (Reuters) Anti–Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a "Hit Hard and Fast" Strategy Improve Outcomes? (CID) Fungal The Last of US Season 2 (YouTube) Oral Wash PCR Improves the Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients Without HIV: A Prospective Multicenter Study (CID) Miscellaneous Foodborne Disease Outbreaks Associated with Marine Toxins — Foodborne Disease Outbreak Surveillance System, United States, 2011–2023 (CDC: MMWR) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

This lecture was recorded by Robin May on the 20th of May 2026 at Barnard's Inn Hall, LondonProfessor of Infectious Disease at the University of Birmingham, and (interim) Chief Scientist at the UK Health Security Agency, Robin May was appointed Gresham Professor of Physic in May 2022. Between July 2020 and September 2025 he served as Chief Scientific Adviser at the Food Standards Agency (FSA).Professor May's early training was in Plant Sciences at the University of Oxford, followed by a PhD on mammalian cell biology at University College London and the University of Birmingham. After postdoctoral research on gene silencing at the Hubrecht Laboratory, The Netherlands, he returned to the UK in 2005 to establish a research program on human infectious diseases. He was Director of the Institute of Microbiology and Infection at the University of Birmingham from 2017-2020. The transcript and downloadable versions of the lecture are available from the Gresham College website: https://www.gresham.ac.uk/watch-now/peoples-emotionsGresham College has offered free public lectures for over 400 years, thanks to the generosity of our supporters. There are currently over 2,500 lectures free to access. We believe that everyone should have the opportunity to learn from some of the greatest minds. To support Gresham's mission, please consider making a donation: https://gresham.ac.uk/support/Website:  https://gresham.ac.ukTwitter:  https://twitter.com/greshamcollegeFacebook: https://facebook.com/greshamcollegeInstagram: https://instagram.com/greshamcollegeSupport the show

It's Monday, June 22nd, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Canadian Parliament passes anti-Bible bill Sadly, Canada's Parliament passed the anti-Bible bill. LifeSiteNews.com reports that a final attempt to stop Bill C-9 was defeated. The bill, which threatens to criminalize quoting parts of the Bible, including on homosexuality, will soon become law. On Wednesday, June 17, a majority of Members of Parliament voted down an attempt by conservative Andrew Lawton to stop Bill C-9 “once and for all.” In an X post, he wrote, that the liberals “voted down my motion to withdraw the divisive and toxic Bill C-9 to stand up for freedom of expression and freedom of religion.”  Another conservative Member of Parliament, Brad Redekopp, called the official passage of Bill C-9 a “dark day” for Canada and religious freedom. The bill was introduced by Justice Minister Sean Fraser last year. Specifically, Bill C-9 would remove Section 319(3)(b) of Canada's Criminal Code.  That's the section which protects the good-faith expression of a person's religious views based on religious texts such as the Holy Bible. Galatians 6:7 declares, “Do not be deceived: God cannot be mocked.” Proof that Fauci funded lab research that sparked COVID A trove of communications and documents released by outgoing Director of National Intelligence Tulsi Gabbard show that Dr. Anthony Fauci “provided millions in U.S. taxpayer dollars to fund dangerous gain-of-function research” on bat coronaviruses at the Wuhan Institute of Virology and that Fauci “lied to Congress,” reports LifeSiteNews.com. In a viral overnight social media video on June 19th already seen by millions, Gabbard made this announcement. GABBARD: “Before the COVID pandemic, Dr. Fauci, as head of the National Institute of Allergy and Infectious Diseases, provided millions in U.S. taxpayer dollars to fund dangerous gain-of-function research on bat coronaviruses at the Wuhan Institute of Virology, work which is now widely viewed as the source of the unintentional lab leak that sparked the pandemic. “Now, in support of President Trump's maximum transparency mandate, today, on my final day as Director of National Intelligence, I'm releasing never-before-seen communications and documents that expose exactly how Fauci worked with politicized career leadership in the Intelligence Community to suppress the truth about his actions, the virus's lab leak origins, and his role in directing U.S. funding for this dangerous research that caused immeasurable harm and countless lost lives. “Now, these documents expose Fauci's direct role in influencing and manipulating [Intelligence Community] assessments on COVID 19, and how Fauci lied to Congress in 2024 when, under oath, he denied knowledge of or participation in discussions with intelligence officials about viral research.” Dr. Fauci's close Intelligence Community relationships enabled him to “assume three key roles during the pandemic that shielded him from scrutiny as he wielded outsized influence.” First, Fauci funded risky coronavirus research linked to Big Pharma and the pursuit of “universal vaccines” worth trillions of dollars. Second, Fauci was the behind-the-scenes advisor who, with his hand-picked experts, pushed the Intelligence Community to endorse a natural, animal origin to hide his dangerous research. And third, Fauci became the nation's pandemic “pundit” and publicly pushed lies, disinformation, and censorship. GOP Senator: Trump's peace deal with Iran seemed elusive Appearing on Fox News Channel on June 17th, Republican Senator Eric Schmitt of Missouri, a member of the Senate Armed Services Committee, expressed his approval of the deal that President Donald Trump negotiated with Iran, reports RealClearPolitics.com. SCHMITT:  “The president of the United States, President Trump, was very clear from the get-go what the mission here was, which was to ensure that Iran would never have a nuclear weapon. They have no ability to do that. And they're signing on the dotted line now, Sean, for the first time, that they're not going to do that. “And we don't need to trust them. We just need to verify that. Effectively, the president knocked out their military capability. Their Navy is at the bottom of the sea. They have no air defense. Their nuclear program is in shambles. It's nowhere near ever being started up again. And we can always go back and mow the lawn, if necessary, because we've got eyes on it. “The president has provided now, through all of that action, space for diplomacy. That has always been his North Star. There's always more things to do. We need to make sure, obviously, we're verifying all of this. But the president has pulled off something here that most experts, six months ago, wouldn't have thought was possible. And I think it's good for the American people.” FBI foiled terrorist plot against UFC 250 event at White House A terror plot targeting the Ultimate Fighting Championship event at the White House on June 14th reportedly involved those who were ready to deploy snipers and drones armed with explosives to carry out a mass casualty attack against U.S. government officials. In a June 16th statement, FBI Director Kash Patel said his agency and its law enforcement partners became aware of the potential threat on June 10. He confirmed that authorities stopped the alleged plot before it began. Patel said, "Thanks to the rapid action of this FBI, our partners, and the Department of Justice in a multi-state operation, multiple individuals are now in custody and allegedly planned attacks were stopped cold. “We are built to detect, respond to, and bring to justice those who threaten the lives of American citizens — particularly during large gatherings like the historic UFC 250 fight" which drew 85,000 people to the Ellipse. James Talarico: God is non-binary; Jesus does not call us to worship Him And finally, James Talarico, the Texas Democrat candidate in the U.S. Senate race against Republican Ken Paxton, has made some bizarre claims about God and Jesus. Listen. TALARICO:  “God is both masculine and feminine, and everything in between. God is non-binary.” And here's what Talarico said about Jesus. TALARICO: “Not once in the entire Bible does Jesus ask us to worship Him. All He asks is that we follow Him.” Pastor Josh Howerton, Senior Pastor of Lakepointe Church in Dallas, Texas, called James Talarico a heretic. HOWERTON: “The whole last book of the Bible is the Lamb is seated on the throne with more people than anybody can count bowing down and worshiping Him, throwing crowns before Him. And then anybody who won't do that, He's throwing them into the lake of fire. “This is not me being mean or exaggerating: he's an actual heretic, like a biblically-defined false teacher and heretic. “Politicians, since the beginning of time, have been twisting Scripture, using Scripture to try to convince people to do what they want. This is the first guy I've ever seen whose whole platform is using the Bible to convince Christians to support godless things.” Revelation 5:13 says, “Then I heard every creature in Heaven and on Earth and under the Earth and on the sea, and all that is in them, saying: “To Him who sits on the throne and to the Lamb be praise and honor and glory and power, for ever and ever!” Close And that's The Worldview on this Monday, June 22nd, in the year of our Lord 2026. Subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Tuesday Headlines: UK PM Sir Keir Starmer resigns Vance says Iran will allow nuclear inspectors Aussie support for multiculturalism plunges in historic survey shift Rare warning from Five Eyes urges leaders to ‘act now’ on powerful new AI models Messi breaks World Cup goal-scoring record Deep Dive:For years, Australia managed to avoid a strain of bird flu that has devastated wildlife populations and agricultural industries across much of the world. That changed over the weekend, after authorities confirmed an infected migratory bird was discovered with H5N1 in Western Australia. In this episode of The Briefing, Chris Spyrou speaks with Professor Paul Griffin, Director of Infectious Diseases at Mater Health, about what we know about the virus, the risks it poses to both humans and animals, and why authorities are urging us to roll up our sleeves for this year’s flu shot to help reduce its impact. Follow The Briefing: TikTok: @thebriefingpodInstagram: @thebriefingpodcast YouTube: @TheBriefingPodcastSee omnystudio.com/listener for privacy information.

Vincent travels to ASM Microbe in Washington DC to speak with John Dye of the United States Army Medical Research Institute of Infectious Diseases about the recent outbreaks of Bundibugyo ebolavirus in Africa and Andes virus on a cruise ship. Host: Vincent Racaniello Guest: John Dye Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

In this must-listen episode, Dr. Ryan Moenster and Dr. Megan Klatt dive deep into the latest infectious diseases trials, guidelines, and novel therapeutics. Staying current in the field is a challenge, but this podcast episode does the legwork for you. Note: BCIDP credit is available for this episode. Google Drive to Slides from Live Session: [https://drive.google.com/file/d/11uHzZoValckfsjUTIdVyAJ35QDSVRfQu/view?usp=sharing](https://drive.google.com/file/d/11uHzZoValckfsjUTIdVyAJ35QDSVRfQu/view?usp=sharing "https://drive.google.com/file/d/11uHzZoValckfsjUTIdVyAJ35QDSVRfQu/view?usp=sharing") How to Obtain BCIDP Recertification Credit for this Episode: Visit https://sidp.org/BCIDPhttps://sidp.org/BCIDPSIDP - BCIDP Recertification for more information SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: https://sidp.org/Become-a-Member Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, Stitcher, Google Play, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/

This episode walks through practical steps travelers can take to avoid getting sick before or during summer trips, and why basic habits like hydration and hand washing make a big difference for family safety. Austin Haberman, Manager of Infection Prevention and Control at Henry Mayo Newhall Hospital, explains hand sanitizer use, cruise ship outbreaks, and how to respond if you fall ill during travels. For more travel safety resources visit library.henrimayo.com and search "travel," and please subscribe to It's Your Health Radio on your favorite podcast app.

It's been one year since the U.S. Centers for Disease Control and Prevention, in an unprecedented move, dismissed all the members of its Advisory Committee on Immunization Practices (ACIP), kicking off what would turn out to be a very concerning and busy year for infectious disease specialists.  We're going to recap this turbulent period – which includes a resurgence of measles, an unusually rough flu season, the emergence of a new COVID strain and outbreaks of hantavirus and Ebola – with Dr. William Schaffner, one of the country's most frequently quoted medical experts on infectious disease, vaccination, and public health. As a member of ACIP for decades, Dr. Schaffner brings unique insight into the dismantling of the committee and the distrust of vaccines that lies at the root of the changes. As he explains to Raise the Line host Lindsey Smith, while many vaccine critics are beyond reach, there are those he describes as vaccine hesitant that may be persuadable if the right approach is taken. “Beyond providing facts, we have to listen to them and respond to their concerns and make them feel comfortable. Information is fundamental, but behavior change only comes with a change in attitude.” Tune in for a wealth of wisdom and context that includes observations on: What's complicating containment of the Ebola outbreak; Challenges in public health communication in the current social media environment; What grade health authorities should get on their response to the hantavirus outbreak. Mentioned in this episode:Vanderbilt University School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this summer-ready episode of "Transmission Interrupted," host Jill Morgan sits down with Dr. Andi Shane, Division Chief for Pediatric Infectious Disease at Emory and Medical Director of the Special Care Unit at Children's Healthcare of Atlanta, to tackle the itchy, the icky, and the often misunderstood risks of summer: bugs, bites, and bathrooms. As families gear up for vacations, outdoor adventures, and the return to school, Jill and Dr. Shane break down the real dangers posed by bug bites and creepy-crawlies, offering practical guidance to parents for preventing itching, infections, and accidental exposures. They discuss best practices for using insect repellents on children, why covering up is sometimes easier said than done, and the importance of checking kids (and pets) for ticks—along with what tick-borne illnesses to watch out for as changing climates shift the landscape of risks across the country. The episode doesn't shy away from common but uncomfortable realities like head lice, exploring why these unwelcome visitors are more gross than genuinely dangerous, and shares expert strategies for dealing with them calmly. Dr. Shane also covers hand hygiene, safe management of public restrooms, and the influx of “cooties” when kids return to school, offering memorable and sometimes hilarious tips for keeping families healthy through the literal and figurative messes of summer. Wrapping up, Jill and Dr. Shane emphasize the ongoing importance of vaccination, regular pediatric care, and practical steps every parent can take to minimize risks and avoid unexpected hospital visits. Whether you're heading to camp, beach, or just the local playground, this episode is your guide to surviving and thriving through bugs, bites, and bathrooms. Questions or comments for NETEC? Contact us at info@netec.org. Visit Transmission Interrupted on the web at netec.org/podcast. Guests Andi Shane, MD, MPH, MSc Professor of Pediatrics and Division Chief, Division of Pediatric Infectious Disease Marcus Professor of Hospital Epidemiology and Infection Control Emory University School of Medicine and Children's Healthcare of Atlanta Andi L. Shane, MD, MPH, MSc joined Children's Healthcare of Atlanta and Emory University in 2006 after completing an Epidemic Intelligence Service (EIS) fellowship at the Centers for Disease Control and Prevention (CDC) and a Pediatric Infectious Disease fellowship at the University of California, San Francisco. Prior to her fellowship, Dr. Shane earned a medical degree from Louisiana State University School of Medicine in New Orleans, followed by residency training with an additional year as a chief resident at Albert Einstein College of Medicine in the Bronx, NY. Dr. Shane has broad experience and interests in the field of pediatric infectious disease, including but not limited to the prevention and management of diarrheal disease, neonatal sepsis, vaccine effectiveness, and the applications of probiotics to infectious disease prevention and mitigation. In addition, she is committed to the care of children with infections with special pathogens in protected care environments working with children's hospital preparedness teams. In her role as Marcus Professor of Hospital Epidemiology and Infection Control, she serves as the Medical Director of Hospital Epidemiology for Children's, collaborating with the Children's infection prevention and industrial hygiene teams. Dr. Shane currently serves as the Division Chief of Infectious Diseases. She holds an adjunct appointment in the Hubert Department of Global Health and is an Emory Global Health Faculty Fellow. Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI) Resources NETEC - WebsiteNETEC - Transmission Interrupted PodcastNETEC - Resource LibraryNETEC - YouTube About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. For more information visit NETEC on the web. NETEC Consultation Services Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting. NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert. For more information visit NETEC Consultation Services.

In this episode of Communicable, Emily McDonald and Josh Davis are joined by Roger Lewis (USA) and Ian Marschner (Australia) to compare and contrast Bayesian and frequentist statistical approaches. The panel discusses the fundamental principles of both methods, common misconceptions, and the extent to which they are often more similar than many realise. Together, they explore their use in clinical trial design, analysis, and reporting, including adaptive trials and sequential learning. Additional topics include sample size misconceptions, regulatory versus clinical thresholds, and the challenges of interpreting post hoc reanalyses of negative trials.This episode was edited by Kathryn Hostettler and the executive producer of Communicable is Angela Huttner.  Further reading:Berry SM, et al. Bayesian Adaptive Methods for Clinical Trials (Chapman & Hall/CRC Biostatistics Series). Boca Raton (FL): CRC Press; 2010. FDA Guidance Document: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products FDA, 2026, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-bayesian-methodology-clinical-trials-drug-and-biological-productsLee TC, et al. Contextualizing the use of corticosteroids in severe Pneumocystis jirovecii pneumonia through a Bayesian lens. CMI Comms 2025, https://www.cmi-comms.org/article/S2950-5909(25)00082-4/fulltextLivingston EH and Lewis RJ. JAMA Guide to Statistics and Methods, https://jamaevidence.mhmedical.com/Book.aspx?bookId=2742Marschner I. Confidence distributions for treatment effects in clinical trials: Posteriors without priors. Stat Med 2024, doi: 10.1002/sim.10000.Whitehead J. The design and analysis of sequential clinical trials. Revised 2nd ed. Chichester: John Wiley & Sons; 1997.

The name "Dr. Jonas Salk" is synonymous with one of the greatest public health achievements of all time: The Polio Vaccine. The arrival of Salk's vaccine in 1955 was a beacon of hope and reinforced the role science can play to serve the public good. When asked who owned the patent for the vaccine, Salk famously replied, "There is no patent. Could you patent the sun?" In 1994, and just one year before Dr. Salk passed, polio was considered eliminated in North and South America. Today, vaccine hesitancy - driven by a host of reasons - has eroded childhood immunization rates in some parts of the country, and reignited a debate over vaccines as a stress test for public trust in science.rnrnContinuing the work of Dr. Jonas Salk is his son, Dr. Peter L. Salk. A graduate from Harvard University and Johns Hopkins University School of Medicine, he would go on to work in his father's laboratory at the Salk Institute for Biological Studies from 1972 to 1984, and again from 1991 to 1995. Together, they would research the biology and immunotherapy of cancer and autoimmune diseases, and develop an inactivated vaccine for HIV infection. Nowadays, Dr. Salk spends his time educating the public regarding his father's life and work and exploring approaches to reducing the severity of various public health problems. Since 2009, Dr. Salk has served as president of the Jonas Salk Legacy Foundation in La Jolla, California. He is also an adjunct professor at the University of Pittsburgh's School of Public Health, Department of Infectious Diseases and Microbiology.rnrnIn partnership with the Mt. Sinai Health Foundation, join us as Dr. Peter L. Salk sits down in conversation with Dr. Arthur Lavin, retired pediatrician and Co-Founder of Grandparents for Vaccines. Together, they will discuss the Salk legacy, the state of public trust in science, and the future of public health.

In episode 79 of Going anti-Viral, we represent a panel discussion from June 9, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, this Dialogue brings together world-class experts Yvonne Maldonado, MD of Stanford University, and Peter Chin-Hong, MD, of the University of California San Francisco. The panel discusses the impact of the World Cup on public health as well as providing updates on current health threats including hantavirus, Ebola, measles, alpha-gal syndrome, and influenza. The panel also provides an update on alpha-gal syndrome and tick-borne diseases, as well as a discussion about an effort by Google to control diseases spread by mosquitoes. Finally, the panelists discuss the risk of the New World screwworm fly to livestock and humans, an outbreak of Campylobacter from the consumption of raw milk, and the impact of the World Cup on influenza in the US.0:00 – Introduction 1:32 – Impact of the World Cup travel on public health7:10 – Lessons learned from the hantavirus outbreak 13:42 – Status of Ebola outbreak, treatment options, and vaccine development25:18 – Update on measles in the US and public health response37:22 – Overview of alpha-gal syndrome and tick-borne diseases42:20 – Update on the Google Debug project45:31 – Risk of the New World screwworm fly to livestock and humans 47:42 – Outbreak of Campylobacter from the consumption of raw milk52:59 – Overview of influenza season in southern hemisphere and risk to the US57:46 – Closing remarks __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Dr. Olga Klinkova, Infectious Diseases clinician at Moffitt Cancer Center and Research Institute, conducts a board review session on Candida Infections targeted towards the medical resident or Infectious Diseases Fellow. Topics discussed include a comparison and contrast of the different Candida species, information on Candida auris, Candidemia, and disseminated (hepatosplenic) candidiasis. Also discussed are novel antifungals used for azole-resistant candidiasis. Guidelines based reference sources are also mentioned.

On episode #108 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 5/21 – 6/3/26. Host: Daniel Griffin and Sarah Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Performance of five mpox antigen-based rapid diagnostic tests tested on lesion swabs from patients with suspected mpox from the Kinshasa province of DR Congo: a diagnostic accuracy study (LANCET: Infectious Diseases) A Phase 3, Randomized Trial ofBulevirtide in Chronic Hepatitis D (NEJM) First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib (CMI: Clinical Microbiology and Infection) Chikungunya Vaccines for Travelers: Unanswered Pragmatic Questions Persist (JID) Bacterial Early Discontinuation of Empiric Antibiotics in Pediatric Haploidentical Hematopoietic Cell Transplant Recipients with Febrile Neutropenia (CID) Methicillin-Resistant Staphylococcus aureus Nasal Swab Utilization as a Predictor for Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: A Systematic Review and Meta-analysis (OFID) Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin: A Randomized Controlled Trial (CID) Fungal The Last of US Season 2 (YouTube) Donor-derived and nosocomial-acquired Candida auris transmission involving solid organ transplant recipients (Infection Control and Hospital Epidemiology) Parasitic Development of a Phase 1 Cryptosporidiosis Controlled Human Challenge Model in Healthy Volunteers Using Current Good Manufacturing Practice Cryptosporidium Parvum Oocysts and Conducted Under an Investigational New Drug Application (JID) Miscellaneous Childhood VaccineHesitancy(NEJM) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Edward Ryan is the director of global infectious diseases at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.T. Ryan, F. Qadri, and J.A. Lynch. Global Cholera-Control Efforts — Progress and Remaining Challenges. N Engl J Med 2026;394:2177-2180.

West Nile was recently discovered in mosquitoes in New Orleans. Let's talk about what the disease is and how it spreads with Dr. Fred Lopez, Professor of Medicine in the Section of Infectious Diseases at LSU Health New Orleans

This member-driven podcast is a benefit of membership of the Arizona Chapter of the American Academy of Pediatrics (AzAAP) and is intended for AzAAP pediatric healthcare members. No information or content in this podcast is intended to substitute or replace a consultation with a healthcare provider or specialist. All non-healthcare providers should reach out to their child's pediatrician for guidance. Music: Wallpaper by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/4604-wallpaperLicense: http://creativecommons.org/licenses/by/4.0/ 

In this bonus episode of Communicable, hosts Anne-Grete Märtson and Angela Huttner invite Martin Grobush (University of Amsterdam; ESCMID Emerging Infections Subcommittee) and Daniel Bausch (National University of Singapore, London School of Hygiene & Tropical Medicine, and Geneva Graduate Institute) to discuss the Bundibugyo ebolavirus outbreak currently ongoing in the Democratic Republic of Congo and Uganda. Clinical and virological differences between Bundibugyo and Zaire ebolaviruses are discussed, as are the particular challenges for diagnosis, treatment, and prevention confronting healthcare workers of this outbreak. The episode accompanies two new publications in CMI Communications and CMI:Gupta N, Mora-Rillo M, Gkrania-Klotsas E, et al. Bundibugyo ebolavirus (BDBV): what first responders/clinicians need to know. CMI Communications, 2026; 2 (DOI: 10.1016/j.cmicom.2026.105207) Gupta N, Marta Mora-Rillo, Gkrania-Klotsas E, et al. Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee. Clin Microbiol Infect, 2026 (DOI: 10.1016/j.cmi.2026.05.042)

Paul Sax, MD, FIDSA sits down with comedy-writer, Mike Reiss, and his wife, Denise Reiss, to discuss a lifetime of travel experiences spanning more than 100 countries. From submarine dives and whale sharks to a hospitalization caused by Shigella, they recount remarkable adventures and the health risks that can emerge when exploring the world.

Africa once again has an Ebola outbreak. At this point, it is centered in the so-called Greak Lakes region, with the largest number of cases in the Democratic Republic of the Congo. Uganda has also seen several cases. Sadly this is not new news. But it takes place in the context of a weakened World Health Organization, with the US withdrawal, and a stark memory of the Covid outbreaks. It also is exacerbated by the shuttering of USAID and severe cuts in health funding from the Trump Administration. The United States is insisting that any American that tests positive for the virus would be treated outside of the country, provoking protests in East Africa such as in Kenya. So is the Ebola outbreak a potential pandemic? What has been the most effective means to treat these kinds of outbreaks. And how does it influence the current intense discourses about health care delivery and wellness in the United States. [ dur: 58mins. ] Heather Wipfli is Professor and Clark Leadership Chair in Global Health at the University of Maryland. She is the co-author of Investigating global mental health: Contributions from political science and Network influences on policy implementation: Evidence from a global health treaty. And she has extensive experience in Uganda. Lawrence Gostin is Faculty Director of the O'Neill Institute for National and Global Health Law and is the Founding O'Neill Chair in Global Health Law at Georgetown Law. He is the co-editor of Global Health Security: A Blueprint for the Future and Global Health Law & Policy: Ensuring Justice for a Healthier World (2023). And he is working with the WHO and the Intergovernmental Negotiation Body (INB) to draft a Pandemic Treaty. His opinion posted in Washington Post titled – “Don’t tell Trump, but the U.S. is still a WHO member” and in The Hill where he co-authored  “America's wrong and unlawful response to Ebola must pivot“. Amesha Adalja, Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health. He is the author of Recognition and Management of Infectious Bio-threats and Emerging Pathogens and AI and the Future of Medical Countermeasures to Protect Against Biological Threats. He has served on US government panels tasked with developing guidelines for the treatment of plague, botulism, and anthrax in mass casualty settings, the system of care for infectious disease This program is produced by Ankine Aghassian, Doug Becker and Sudd Dongre. Health, Infectious Diseases, Public Health and Safety, Uganda, Democratic Republic of the Congo

In this episode, we host Professor Meru Sheel to examine whether global health systems are prepared for the next major infectious-disease outbreak. Drawing on her work in infectious-disease epidemiology, vaccine research, emergency preparedness and global health security, Professor Sheel explores the difficult questions now facing governments, public-health agencies and international institutions: how quickly outbreaks can be detected, how effectively information is shared, and how public-health systems can respond before local emergencies become wider international crises. Set against the recent Ebola outbreak in the Democratic Republic of the Congo and Uganda, and the international response to the MV Hondius hantavirus outbreak, this conversation looks at the race between disease spread, surveillance, public trust and political coordination.We discuss why outbreaks test far more than medicine alone. Professor Sheel explains how public-health responses depend not only on vaccines, diagnostics and contact tracing, but also on logistics, risk communication, community engagement and trust in institutions. We explore the difference between individual severity and population-level risk, why a virus can be highly fatal without necessarily posing a pandemic-style threat, and why public-health messaging must warn people without creating panic. The episode also examines the role of the International Health Regulations, the World Health Organization, national governments and multidisciplinary response teams in managing complex, cross-border outbreaks involving cruise ships, repatriation, quarantine, clinical care and international contact tracing.Professor Meru Sheel is Professor of Infectious Diseases and Global Health at the University of Sydney. Her work focuses on epidemiology, vaccine research, outbreak preparedness, emergency response and immunisation systems, particularly across Australia and the Asia-Pacific region. She has worked extensively on the relationship between routine vaccination systems and health emergency preparedness, and her research examines how surveillance, community engagement, vaccine delivery, public-health coordination and equity shape the ability of countries to prevent, detect and respond to infectious-disease threats. The International Risk Podcast brings you conversations with global experts, frontline practitioners, and senior decision-makers who are shaping how we understand and respond to international risk. From geopolitical instability and organised crime to cybersecurity threats and hybrid warfare, each episode explores the forces transforming our world and what smart leaders must do to navigate them. Whether you're a board member, policymaker, or risk professional, The International Risk Podcast delivers actionable insights, sharp analysis, and real-world stories that matter.Dominic Bowen is the host of The International Risk Podcast and Europe's leading expert on international risk and crisis management. As Head of Strategic Advisory and Partner at one of Europe's leading risk management consulting firms, Dominic advises CEOs, boards, and senior executives across the continent on how to prepare for uncertainty and act with intent. He has spent decades working in war zones, advising multinational companies, and supporting Europe's business leaders. Dominic is the go-to business advisor for leaders navigating risk, crisis, and strategy; trusted for his clarity, calmness under pressure, and ability to turn volatility into competitive advantage. Dominic equips today's business leaders with the insight and confidence to lead through disruption and deliver sustained strategic advantage.Subscribe for all our updates!Tell us what you liked!

In episode 78 of Going anti-Viral, Dr Rajesh T. Gandhi joins host Dr Michael Saag to discuss the process of guidelines development. Dr Gandhi is a Professor of Medicine at Harvard Medical School and Principal Investigator and Co-Director of the Harvard University Center for AIDS Research (CFAR). Dr Gandhi is the Vice-Chair of the ACTG, Vice-Chair of the Infectious Diseases Society of America COVID-19 Treatment Guidelines Panel, Chair of the International Antiviral Society-USA Panel on Antiretroviral Drugs for Treatment and Prevention of HIV in Adults, and the Lead Editor for Infectious Diseases, NEJM Clinician. Dr Gandhi and Dr Saag explore the intricate process of developing HIV treatment guidelines, including evidence review, panel selection, and updates on new topics like transgender care and substance use disorders. They discuss how guidelines are created, their impact on clinical practice, and future directions in HIV care.0:00 – Introduction 1:54 – The purpose and impact of guidelines4:00 – Panel composition and selection process6:00 – Guideline structure and key updates12:34 – Emerging topics: transgender care and transplant medicine14:31 – Substance use disorders and treatment innovations16:03 – Evidence-based recommendations and their strength22:07 – Guidelines development process and team dynamics24:42 – Living guidelines versus published documents28:41 – Closing thoughts and future directionsResources: Going-anti-Viral: Episode 32 - Update on the New Antiretroviral Therapy Guidelines - Dr Rajesh GandhiYouTube:  https://youtu.be/G7FQTInz-dY Apple Podcasts:  https://podcasts.apple.com/us/podcast/episode-32-update-on-the-new-antiretroviral-therapy/id1713226144?i=1000678818027 __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

The benefits of getting a shingles vaccine seem relatively straightforward: It will prevent you from getting shingles, a painful rash caused by the same virus that causes chickenpox. But researchers have found a surprising link between getting the shingles vaccine and a lower risk of developing dementia. And that's not the only vaccine that seems to have additional benefits. So what's going on here?  To help explain this research are epidemiologist Pascal Geldsetzer, who studies the association between the shingles vaccine and lower rates of dementia; and physician and epidemiologist Helen Chu, who studies the Flu, RSV and COVID-19 viruses. Guests: Dr. Pascal Geldsetzer is an assistant professor of medicine, epidemiology and population health at Stanford University.  Dr. Helen Chu is a professor of epidemiology, allergy and infectious diseases at the University of Washington.  Other episodes you may enjoy: Study Finds COVID mRNA Vaccines Boost Cancer Treatment As Cervical Cancer Deaths Plummet, Experts Credit HPV Vaccine Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Human Immunodeficiency Virus, or HIV, remains one of the most important infectious diseases in modern healthcare, but advances in antiretroviral therapy have transformed it from a fatal diagnosis into a manageable chronic condition for many patients. In this episode, we'll break down the major medication classes used to treat HIV, discuss how these drugs work, review key adverse effects and drug interactions, and highlight practical nursing considerations that impact patient safety and adherence. Whether you work in acute care, outpatient practice, long-term care, or public health, understanding HIV pharmacology is essential to providing compassionate, evidence-based care for patients living with HIV and AIDS. You can find the full 16+ hour nursing pharmacology review course, including PDF handouts, cheat sheets, practice questions, and on-demand videos at meded101.com!

On episode #107 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 5/7 – 5/20/26. Host: Daniel Griffin and Sarah Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV) (Gileadl) A Phase 3, Randomized Trial ofBulevirtide in Chronic Hepatitis D(NEJM) Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) (NLM: ClinicalTrials.gov) Andes Hantavirus Outbreak on a Cruise Ship, 2026 (NEJM) Quick takes: Another hantavirus case, polio in 3 countries, NIAID head steps down (CIDRAP) Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial (CID) Dolutegravir Appears to Lower Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) Proviral Load: The Emerging Rational Approach to Treatment of HTLV-1–Associated Myelopathy (CID) Use of Dolutegravir for treatment of HTLV-1 (CID) Use of dolutegravir to treat people living with HTLV-1-associated myelopathy (HAM) (CID) Bacterial Urinary Tract Infection (UTI)-free and Recurrent UTI (rUTI)-Free Survivals Following Bladder Electrofulguration in Women With a History of Antibiotic-Refractory rUTI (OFID) Azithromycin for Preschoolers with Wheezing in the Emergency Department (JAMA) Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care (JAMA Internal Medicine) Fungal The Last of US Season 2 (YouTube) Changes in Epidemiology of Candidemia in the United States With a Focus on Candida auris (CID) Parasitic Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme (The LANCET) Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement  (JAMA Network OPEN) Febrile Temperature Augents Ring-stage Plasmodium falciparum Adhesion to Brain Endothelial Cells (JID) An Increase in Imported Plasmodium vivax Malaria in New York City: Clinical and Demographic Trends Following Recent Migration (OFID) Miscellaneous The State of Physician Leadership (WittkKieffer) Infectious Diseases Fellowship Curriculum: IDSA Training Program Directors Community of Practice (TPDCOP), Curricular and Educational REsources Workgroup (CREW) (CID) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Fungal infections are commonly encountered across healthcare settings, ranging from oral thrush and vaginal yeast infections to serious systemic infections in critically ill patients. In this episode, we'll review the major antifungal medications nurses should know, including azoles, echinocandins, polyenes, and topical antifungals. We'll focus on practical nursing considerations such as monitoring for adverse effects, recognizing important drug interactions, administration tips, and patient education points. By the end of the episode, listeners will have a stronger understanding of how antifungal medications work and how nurses play a key role in ensuring safe and effective treatment. You can find the full 16+ hour nursing pharmacology review course, including PDF handouts, cheat sheets, practice questions, and on-demand videos at meded101.com!

Yascha Mounk and Marc Lipsitch also discuss how worried we should be about Hantavirus and Ebola. Marc Lipsitch is the Berberian Professor at Stanford University, with appointments in Infectious Diseases, Biology, and the Center for International Security and Cooperation. In this week's conversation, Yascha Mounk and Marc Lipsitch discuss the good, the bad, and the ugly of gain-of-function research, how scientific incentives may be encouraging risky experimentation—and the recent outbreaks of hantavirus and ebola. If you have not yet signed up for our podcast, please do so now by following this link on your phone. Email: leonora.barclay@persuasion.community Podcast production by Mickey Freeland and Leonora Barclay. Connect with us! Spotify | Apple | Google X: @Yascha_Mounk & @JoinPersuasion YouTube: Yascha Mounk, Persuasion LinkedIn: Persuasion Community Learn more about your ad choices. Visit megaphone.fm/adchoices

This nursing pharmacology review covers the essential antiviral medications commonly encountered in clinical practice and on nursing exams. The video explains how antiviral drugs work, what infections they treat, and the key nursing considerations for safe medication administration and monitoring. Major medications discussed may include acyclovir, valacyclovir, oseltamivir, antiretroviral therapy, and other commonly prescribed agents. You can find the full 16+ hour nursing pharmacology review course, including PDF handouts, cheat sheets, practice questions, and on-demand videos at meded101.com!

This nursing pharmacology review provides a high-yield overview of the most important antibiotic classes used in clinical practice. The video explains how common antibiotics work, what infections they treat, and the major nursing considerations associated with each class. Key topics include penicillins, cephalosporins, macrolides, fluoroquinolones, tetracyclines, vancomycin, aminoglycosides, and sulfonamides. Emphasis is placed on side effects, black box warnings, allergy considerations, renal dosing, patient counseling, and critical monitoring parameters nurses should recognize in both inpatient and outpatient settings. You can find the full 16+ hour nursing pharmacology review course, including PDF handouts, cheat sheets, practice questions, and on-demand videos at meded101.com!